InvestorsHub Logo
Followers 3183
Posts 208744
Boards Moderated 2
Alias Born 02/04/2004

Re: subslover post# 52372

Thursday, 07/28/2022 9:59:53 AM

Thursday, July 28, 2022 9:59:53 AM

Post# of 64318

“While the Company’s main focus is the Phase III clinical trial using JadiCells for treatment of COVID-19 ARDS and concurrently advancing our pipeline and intellectual property, our focus is to generate the most cutting-edge science we can and accelerate its clinical translation alone or through partnerships.” said Dr. Boris Reznik, Scientific Advisory Board Member of the Company.



Never buy or sell based on my posts! My posts are just my opinion!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News